Who has invested in DIOSynVax?

CEPI are named among the investors backing DIOSynVax.

DIOSynVax Funding: $42M Raised, Series A (2022)

DIOSynVax funding overview

DIOSynVax is based in Hertford, England. DIOSynVax has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for DIOSynVax runs through 2022; nothing later has been disclosed. Investors on record include CEPI.

DIOSynVax at a glance

Total raised: $42M
Latest round: Series A
Latest round date: April 2022
Headquarters: Hertford, England
Notable investors: CEPI

Frequently asked about DIOSynVax funding

How much has DIOSynVax raised?: DIOSynVax has raised $42M in total disclosed funding across the rounds on record.
Who has invested in DIOSynVax?: CEPI are named among the investors backing DIOSynVax.
What was the latest DIOSynVax funding round?: The most recent disclosed round is a Series A, announced in April 2022.
Where is DIOSynVax based?: DIOSynVax is based in Hertford, England.
When did DIOSynVax last raise?: The last disclosed DIOSynVax round closed in April 2022 at Series A.

We update the DIOSynVax record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hertford and their backers are listed below.

DIOSynVax Funding: $42M Raised, Series A (2022)

DIOSynVax funding overview

DIOSynVax at a glance

Frequently asked about DIOSynVax funding

Companies related to DIOSynVax (35)

Browse related funding lists (3)